Dexcom to Launch New Continuous Glucose Monitor

March 27, 2018. Dexcom has received US Food and Drug Administration approval for its new G6 real-time continuous glucose monitor, with an expected US launch between April and June of this year. The G6 is factory-calibrated and does not require a fingerstick. It can be worn continuously for up to 10 days, does not interfere with acetaminophen, and is approved for patients aged 2 years and older. The hardware includes a new one-button insertion, and the device is about two-thirds the original size. The G6 improves on both the accuracy and convenience of the G5, making daily diabetes management more feasible. Read about the device here.